Antiretroviral Stock-Outs and Clinic Attrition Impact HIV Outcomes in Libya
A mixed-methods investigation at Tripoli Central Hospital reveals that antiretroviral drug stock-outs drive most treatment modifications, while loss to follow-up ...
A mixed-methods investigation at Tripoli Central Hospital reveals that antiretroviral drug stock-outs drive most treatment modifications, while loss to follow-up ...
A longitudinal study protocol outlines a life cycle assessment comparing greenhouse gas emissions from medical drone deliveries of antiretroviral therapy ...
A 20-year retrospective study found that people with HIV starting integrase inhibitor regimens experienced greater early increases in serum uric ...
A ten-year prospective cohort study in Guangxi, China, reveals that heterosexual individuals experience significantly slower CD4+ T cell recovery and ...
A systematic review of 34 clinical trials indicates that engineered combination broadly neutralizing antibodies extend circulation and delay HIV-1 rebound ...
A retrospective study of US claims data found that 32.3% of adults living with HIV discontinued their initial antiretroviral regimen ...
A 30-year retrospective cohort study in Tunisia revealed that AIDS-defining malignancies predominated among young people living with HIV presenting with ...
A post hoc analysis of the phase 3 BRIGHTE study found that fostemsavir-based regimens maintained durable virologic suppression and immunologic ...
A retrospective study of over 22,000 commercially insured US adults on antiretroviral therapy found that 44.2 percent had potential drug ...
A narrative review demonstrates that dual antiretroviral regimens sustain viral suppression while improving treatment flexibility and adherence.
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine